VOYA Investment Management
VNDA icon

VOYA Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

VOYA Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.6K Sell
10,216
-386
-4% -$2.98K ﹤0.01% 2237
2025
Q4 		$93.5K Sell
10,602
-297
-3% -$1.64K ﹤0.01% 2274
2025
Q3 		$54.4K Sell
10,899
-5,502
-34% -$25.5K ﹤0.01% 2376
2025
Q2 		$77.4K Buy
16,401
+505
+3% +$2.21K ﹤0.01% 2536
2025
Q1 		$73K Sell
15,896
-2,579
-14% -$12K ﹤0.01% 2487
2024
Q4 		$88.5K Sell
18,475
-1,317
-7% -$6.32K ﹤0.01% 2603
2024
Q3 		$92.8K Buy
19,792
+454
+2% +$2.43K ﹤0.01% 2681
2024
Q2 		$109K Sell
19,338
-237
-1% -$1.22K ﹤0.01% 2642
2024
Q1 		$80.5K Sell
19,575
-5,757
-23% -$23K ﹤0.01% 2659
2023
Q4 		$107K Sell
25,332
-60,424
-70% -$244K ﹤0.01% 2740
2023
Q3 		$370K Sell
85,756
-34,817
-29% -$193K ﹤0.01% 2201
2023
Q2 		$795K Buy
120,573
+991
+0.8% +$6.35K ﹤0.01% 1814
2023
Q1 		$812K Buy
119,582
+3,660
+3% +$25.7K ﹤0.01% 1780
2022
Q4 		$857K Buy
115,922
+31,588
+37% +$308K ﹤0.01% 1727
2022
Q3 		$833K Buy
84,334
+2,998
+4% +$31.7K ﹤0.01% 1723
2022
Q2 		$886K Buy
81,336
+101
+0.1% +$1.05K ﹤0.01% 1482
2022
Q1 		$919K Buy
81,235
+14,492
+22% +$191K ﹤0.01% 1526
2021
Q4 		$1.05M Buy
66,743
+1,989
+3% +$34.7K ﹤0.01% 1524
2021
Q3 		$1.11M Buy
64,754
+1,285
+2% +$22.5K ﹤0.01% 1492
2021
Q2 		$1.36M Sell
63,469
-948
-1% -$17K ﹤0.01% 1414
2021
Q1 		$968K Buy
64,417
+9,434
+17% +$153K ﹤0.01% 1609
2020
Q4 		$722K Buy
54,983
+12,840
+30% +$155K ﹤0.01% 1689
2020
Q3 		$407K Sell
42,143
-480
-1% -$5.13K ﹤0.01% 1788
2020
Q2 		$488K Sell
42,623
-7,961
-16% -$90.1K ﹤0.01% 1684
2020
Q1 		$524K Buy
50,584
+6,975
+16% +$86.5K ﹤0.01% 1601
2019
Q4 		$716K Buy
43,609
+2,722
+7% +$41.2K ﹤0.01% 1663
2019
Q3 		$543K Sell
40,887
-157
-0.4% -$2.19K ﹤0.01% 1702
2019
Q2 		$578K Buy
41,044
+638
+2% +$10.2K ﹤0.01% 1680
2019
Q1 		$743K Buy
40,406
+18,752
+87% +$427K ﹤0.01% 1538
2018
Q4 		$566K Buy
21,654
+1,060
+5% +$24.9K ﹤0.01% 1643
2018
Q3 		$473K Hold
20,594
– – ﹤0.01% 1868
2018
Q2 		$392K Buy
20,594
+476
+2% +$7.96K ﹤0.01% 1977
2018
Q1 		$339K Hold
20,118
– – ﹤0.01% 2036
2017
Q4 		$306K Hold
20,118
– – ﹤0.01% 2127
2017
Q3 		$360K Hold
20,118
– – ﹤0.01% 2065
2017
Q2 		$328K Buy
20,118
+4,605
+30% +$66.4K ﹤0.01% 2097
2017
Q1 		$217K Hold
15,513
– – ﹤0.01% 2236
2016
Q4 		$247K Sell
15,513
-3,304
-18% -$53.1K ﹤0.01% 2174
2016
Q3 		$313 Hold
18,817
– – ﹤0.01% 2017
2016
Q2 		$211K Hold
18,817
– – ﹤0.01% 2229
2016
Q1 		$157K Hold
18,817
– – ﹤0.01% 2290
2015
Q4 		$175K Hold
18,817
– – ﹤0.01% 2341
2015
Q3 		$212K Sell
18,817
-5,080
-21% -$62.1K ﹤0.01% 2243
2015
Q2 		$303K Hold
23,897
– – ﹤0.01% 2261
2015
Q1 		$222K Hold
23,897
– – ﹤0.01% 2389
2014
Q4 		$342K Hold
23,897
– – ﹤0.01% 2183
2014
Q3 		$248K Hold
23,897
– – ﹤0.01% 2378
2014
Q2 		$387K Sell
23,897
-1,898
-7% -$25.3K ﹤0.01% 2171
2014
Q1 		$419K Hold
25,795
– – ﹤0.01% 2098
2013
Q4 		$320K Hold
25,795
– – ﹤0.01% 2274
2013
Q3 		$283K Hold
25,795
– – ﹤0.01% 2327
2013
Q2 		$208K Buy
+25,795
New +$174K ﹤0.01% 2482

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's VNDA Position: Q1 2026 in Review

VOYA Investment Management reduced its Vanda Pharmaceuticals (VNDA) stake by 3.6% in Q1 2026, selling an estimated $2.98K and leaving 10,216 shares worth $70.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

VOYA Investment Management first reported a position in VNDA in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.36M in Q2 2021. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • VOYA Investment Management held 10,216 shares of Vanda Pharmaceuticals worth $70.6K as of Q1 2026.
  • VOYA Investment Management sold 386 Vanda Pharmaceuticals shares in Q1 2026, an estimated $2.98K.
  • Vanda Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2237 holding.
  • VOYA Investment Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Vanda Pharmaceuticals position peaked at $1.36M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.